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Nutrition, cancer and healthy ageing 
PG Pelicci and L Titta 
Division of Experimental Oncology, European Institute of Oncology, 
Milano, Italy 
Cancer is a disease of genes, which are vulnerable to beneficial 
and harmful mutations, especially over the long human lifespan. 
Nutritional factors are important in determining the likelihood of 
some mutations, as well as in changing gene function even 
without mutation. Epidemiological and experimental evidence 
demonstrate that only a small proportion of cancers are 
inherited; environmental factors are the most important cause of 
genetic modification. These factors include smoking, infectious 
agents, radiation, industrial chemicals and pollution and 
medication. Nutrition, physical activity and body composition 
can also play a role. Essentially this is good news. It means that 
a healthy lifestyle can stop cancer before it starts. 
In this context, nutrition represents an extraordinary tool to 
prevent cancer. It is already known that being overweight or 
obese increases the cancer risk; a healthy diet could reduce 
this. Furthermore, there is evidence to indicate that bioactives in 
the diet play an important role in promoting health. Validating 
health effects of foods and food components represents the 
new target of nutrition research together with understanding 
mechanisms through which diet factors could prevent disease. 
However, healthy nutritional guidelines are partially known and 
poorly practiced, others could be established and implemented. 
Nutritional improvement requires multiple intervention levels:  
(a) Research  
(b) Health system  
(c) Communication and food industry 
The aim of our project ‘The Food Chance’ is devoted to 
developing nutritional improvement at all levels, taking 
advantage of our already existing network. The potential 
benefits of the project include: increased focus on diet and 
lifespan, motivate positive behaviour change, increased 
awareness of risk of certain conditions, improve health and 
healthy ageing, focus on prevention, reduce health care costs, 
better understanding of the mechanism involved in disease 
susceptibility. 
(a) Research: different fields of research are involved in the 
project. Basic research is dedicated to identifying mechanisms 
and markers of obesity cancer promotion, the fundamental 
activities will include:  
1.  The role of caloric intake and fat development in 
tumorigenesis.  
2.  The effect of obesity on epithelial and haematopoietic 
mouse stem cell compartment.  
3.  The investigation into the epigenome of caloric 
restriction and obesity in mouse stem cells.  
4.  The identification of specific epigenetic modifications 
induced by fat in mouse stem cells and validation in 
humans.  
Furthermore, a metabolism laboratory will study the following:  
- genetics of the metabolism of bioenergetics  
- aerobic metabolism and oxidative stress  
- mitochondrial cellular crosstalk  
- mitochondrial role in aging and cancer. 
Finally, the dietary components that could have beneficial 
effects on health, i.e. in preventing chronic diseases or 
ameliorating general wellness will be investigated by carrying 
out a literature analysis and diet intervention trials in which 
subjects are assigned to a dietary treatment intervention and 
their outcomes measured. 
The direct effect of diet on a range of disease states can be 
assessed. Research focuses mainly on dietary macro and 
micronutrients and their effects on chronic disease 
(cardiovascular disease, cancer, diabetes type 2).  
(b) Health system: represents a fundamental area for any 
prevention policy. In the project, we plan many activities in our 
hospital strongly linked with the other areas: dietary intervention 
studies program on healthy volunteer and patients release of 
informative material for hospital staff, patients and visitors 
canteen and hospital kitchen reorganization following best 
guidelines, specific hospital staff training.  
(c) Communication and food industry: by providing clear 
recommendations of the efficacy of particular food-related 
components to confer protection against target diseases and 
reliable estimates of active compound levels in a directory of 
foods; this programme will result in a recipe for promoting health
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through diet that will appeal to the diversity of tastes of 
consumers. 
 
Nutrition and surgery: state of the art  
R Biffi 
Division of Abdomino-Pelvic Surgery, European Institute of Oncology, 
Milano, Italy 
 
Background  
Over the years, enteral nutrition (EN) has gained considerable 
popularity due to its favourable effects on the digestive tract, its 
lower cost and rate of complications compared to parenteral 
nutrition. 
However, clinicians are often faced with contradictory data and 
difficult decision making when having to determine the optimal 
modalities of EN administration. An example of such a difficulty 
is the precise definition of the expected morbidity rate of needle 
catheter jejunostomy (NCJ). Some findings suggest that NCJ is 
associated with a significant rate of early and late complications; 
in some instances, they may be life threatening and require 
surgical intervention. In this scenario, the role of NCJ in 
providing nutritional therapy to depleted patients undergoing 
major gastrointestinal procedures should be re-examined. 
We prospectively evaluated the rate and type of early and late 
complications associated with NCJ in patients undergoing 
surgical treatment for upper gastrointestinal malignancies. 
 
Methods  
Three hundred and eighty consecutive patients underwent NCJ 
implant according to Delany's method at the end of their 
scheduled surgical procedure (total/subtotal gastrectomy = 242; 
duodenopancreatectomy = 45; esophagectomy = 78; other 
procedures = 15). The EN program was started on post-
operative day (pod) 1 in the surgical ICU with 15 ml/h and 
progressed to the optimal goal of 80 ml/h by post-operative day 
5, using a nutritionally complete liquid polymeric diet providing 1 
kcal/ml. 
Clinical examination and adverse gastrointestinal symptoms 
were recorded on a daily basis. 
Short-term complications directly attributable to the NCJ were 
defined as tube leakage with intra-abdominal or intraparietal 
spillage, intra-abdominal abscess, small bowel obstruction at 
the catheter site, tube blockage or dislodgement or soft tissue 
infection. The NCJ was always removed in the outpatient clinic 
after hospital discharge. Regular follow-up visits were 
conducted in all cases until the patient died or the study was 
closed, in order to detect long-term complications, including 
operations to correct adhesions or small bowel obstruction. 
 
Results 
All the Patients received the EN program for a mean of 14 pod 
(range: 8–46); a single short-term complication of the NCJ has 
been observed in this series (tube blockage; third pod). An easy 
resolution has been obtained with percutaneous replacement 
under x-ray control. No late complications have been detected 
after a mean follow-up of 24.01 months (range: 2–42). 
 
Discussion 
Extensive effort has been made to improve outcome of patients 
undergoing major surgical procedures of the upper 
gastrointestinal tract, and nutrition support is now recognized an 
essential component of the clinical management of these 
patients. The ability to deliver nutrition enterally after an 
operation has been a significant advance and the NCJ gained 
popularity, leading some investigators to recommend 
prophylactic jejunostomy at the time of any high-risk abdominal 
operation, emphasizing the substantial safety and the relatively 
low cost of this additional procedure. However, a few studies 
investigated prospectively the rate of complications arising from 
the NCJ, and limited data are provided from the medical 
literature coming from randomized trials. Zapas et al [1] carried 
out a benefit/risk analysis, comparing complication rate, 
avoidance of parenteral nutrition and discontinuation of 
jejunostomy feeding in 92 patients [1], concluding that the 
benefit/risk ratio is low, mainly due to the significant rate of 
complications related to the placement procedure. Although 
many reports of the use of NCJ have shown very low major 
complication rate, ranging from 0 to 2% [2,3,5–7] in different 
clinical setting, Eddy et al [8] published a paper analysing 
retrospectively their experience in 122 patients observed in a 
Level I Trauma Centre, indicating 14% of short-term 
complications (8% serious) independent from injury severity 
score, trauma mechanism and site of injury and surgeon. The 
results of this series lead them to postulate that NCJ may be, at 
last in trauma patients, associated with a significant rate of 
potentially disastrous complications. The weakness of this study 
 3  www.ecancermedicalscience.com 
C
o
n
f
e
r
e
n
c
e
 
R
e
p
o
r
tecancer 2010, 4:205 
 
are those common to any retrospective review; moreover, it is 
possible that trauma patients are more prone than general 
surgery patients to develop serious complications, particularly if 
an etiologic role for dehiscence of jejunostomy and the 
formation of an enterocutaneous fistula at the exit site of the 
catheter could be attributed to the shrinkage of the oedema 
creating a space between the catheter, the bowel wall and the 
abdominal wall thus facilitating the leak of the jejunostomy. 
A small prospective randomized study has investigated the 
safety and efficacy of enteral feeding by jejunostomy in patients 
undergoing elective esophagogastrectomy [4], comparing the 
clinical outcomes of 25 patients, 13 receiving immediate post-
operative enteral feeding and 12 given a routine diet 
advancement and no feeding jejunostomy. Again, there were no 
major complications related to placement of the feeding tube, 
and there was a trend for patients fed via jejunostomy to have a 
shorter hospital stay, thus confirming that early enteral feeding 
by jejunostomy tube, placed at the time of 
esophagogastrectomy, is a safe means of providing post-
operative nutrition support in selected patients. 
As the benefits of early enteral feeding over total parenteral 
nutrition in terms of reduction of septic morbidity and lower 
costs are indisputable and demonstrated by a number of 
randomized trials, a possible solution to overcome the NCJ-
related morbidity could be the reconsideration of the NCJ as the 
sole way to provide effective enteral nutrition in the post-
operative period, in favour of an intrajejunal feeding initiated via 
a nasally passed tube. No data coming from well-designed 
randomized trials are presently available about this specific 
issue; nevertheless, the compliance of the patients towards this 
approach should be considered as a possible, major limiting 
factor, as at least 27% of nasally passed tubes for enteral 
nutrition are expected to be voluntarily or accidentally removed 
within a few days after placement [8]. 
Finally, a large series (500 consecutive cases) recently 
published by a monocentric experience [9] showed only three 
major complications: small bowel obstruction and pneumatosis 
intestinalis in two patients, respectively; minor complications, 
including diarrhoea and abdominal distension, occurred in 15% 
of patients, whereas subcutaneous infection at the insertion site 
and catheter occlusion precluding use have been detected in 
just 1% of cases. The results of our prospective non-
randomized study agree with these data: complications are 
essentially confined to diarrhoea and abdominal distension and 
can be controlled in the vast majority of the cases with a strict 
adherence to standardized treatment protocols and appropriate 
reduction of the nutrient flow. In addition, long-term morbidity is 
very rare and should not be considered as a significant factor in 
the decision to perform this procedure. 
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DIANA 5 trial at the IEO: the role of the 
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The Diana 5 (Diet and Androgens) trial is a multicentric study 
promoted by the Istituto Nazionale dei Tumori of Milan that 
involves several centres in Italy, including the European Institute 
of Oncology. 
It is an open-label randomized trial based on a change in diet 
and physical activity in order to reduce the risk of breast cancer 
recurrence after surgery in individuals receiving conventional 
cancer management. 
Previous Diana trials showed that a diet that keeps low serum 
insulin levels promotes weight loss, testosterone and insulin 
decrease and reduces oestrogens and IGF-I bioavailability both 
in healthy women and in breast cancer survivors [1–2]. Other 
studies showed that an increase in physical activity is 
associated with a significant reduction in insulin resistance, 
body weight and risk of some cancer types [3–7]. The WINS 
(Women’s Intervention Nutrition Study) study suggests an 
improvement in relapse-free survival of breast cancer patients 
through a healthy diet [8]. 
Eligibility criteria are: women, ages 35–70 years, with invasive 
breast carcinoma, diagnosed in the last five years, with no 
recurrences or other tumours. 
Women with hormone negative breast cancer can be included 
in the study independently of metabolic characteristics. 
Women with breast cancer sensitive to hormones can be 
included in the study if at least one of the following endocrine--
metabolic characteristics is present: 
(a)  Levels of serum testosterone: ≥ 0.4 ng/ml. 
(b)  Levels of serum insulin: ≥7 µU/ml (50 pmol/l). 
(c)  Metabolic syndrome (three of the following factors): 
1.  Glycaemia  ≥ 100 mg/dl (or therapy for 
hyperglycaemia). 
2.  Triglycerides ≥150 mg/dl (or therapy for high 
triglycerides). 
3.  HDL <50 mg/dl (or therapy for 
hypercholesterol). 
4.  Waist circumference ≥ 88 cm.  
5.  Blood pressure ≥ 130/85 mmHg (or therapy 
for hypertension). 
This trial lasts one year and will have a follow-up of five years. 
Women are randomized to the intervention or control groups. 
Women of both groups receive the ‘cancer prevention 
decalogue’ of the World Cancer Research Fund [9].  
Patients in the intervention group get further information within 
cooking classes, gymnastics classes, common meals and 
meetings.  
The Diana 5 trial started at IEO in 2009 and patient recruitment 
is currently in progress. The trial requires a multidisciplinary 
approach, involving an oncologist, a biologist, a dietician and a 
research nurse. 
The dietician has to perform an anthropometric evaluation, 
which includes also the bioimpedenziometric analysis (with the 
use of Tanita
® scale), at the beginning of the study and during 
follow-up. 
The dietician also has to illustrate and discuss with the patients 
the main points of the World Cancer Research Fund 
recommendations. 
The dietician contact each patient by telephone 10 times during 
the first year of the study to get information about physical 
activity and food eaten during the previous day. 
The 24-h dietary recall does not include questions about food 
servings, but only questions about type of food consumed. Food 
intake-recall strategy requires the presence of adequately 
trained staff. 
The dietician is important in the multidisciplinary team to make 
an accurate anthropometric evaluation, an educational activity 
at the beginning and during the first year of the study and 
dietary intake recording through 24-h dietary recall [10]. 
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Is there a role for vitamin D in cancer?  
S Gandini 
Division of Epidemiology, European Institute of Oncology, Milan, Italy 
Calcitriol (1,25(OH)D), the biologically active form of vitamin D, 
has been shown to be an anti-proliferative, pro-differentiation, 
pro-apoptotic agent and an inhibitor of cell migration. The 
vitamin D receptor (VDR) is a crucial mediator for the cellular 
effects of vitamin D and additionally interacts with other cell-
signalling pathways that influence cancer development. 
Alterations in vitamin D receptor expression and in the synthesis 
and catabolism of vitamin D metabolites are involved in the 
growth regulation of tumours, thus, compromising calcitriol 
sensitivity and signalling.  
Cultured melanoma cells can synthesise 1,25(OH)D from 25-
hydroxyvitamin D (25(OH)D), express the VDR, and the anti-
proliferative and pro-differentiation effect of 1,25(OH)D have 
been shown in human malignant melanoma (MM) cells. The 
1,25(OH)D molecule has been shown to induce apoptosis in a 
human MM cell line in vitro, and an inhibitory effect on the 
spread of MM cells has recently been demonstrated in vitro.  
 
Preliminary results  
Epidemiological data indicate that vitamin D deficiency is 
relatively common in Europe. In an Italian study, we found that 
85% of the participants had insufficient level of circulating 
25(OH)D. We show that vitamin D supplementation was 
associated with a significant reduction (7%) in total mortality in 
healthy subjects. When we looked at cancer risk, we showed 
consistent inverse relationship between serum 25-
hydroxyvitamin D levels and colorectal cancer incidence. For 
breast cancer, results were heterogeneous by study design; in 
fact, serum 25(OH)D level are measured after the diagnosis of 
cancer and a reverse causation problem can occur. 
We also showed, through a meta-analysis of the association 
between the two most studied VDR polymorphisms (FokI and 
BsmI), that these polymorphisms might modulate the risk of 
cancer of breast, skin and prostate and possibly affect cancer 
risk at any site in Caucasians. 
A cohort study investigated the hypothesis that higher vitamin D 
levels reduce the risk of relapse from melanoma. The survival 
analysis showed that higher 25(OH)D levels, at diagnosis, were 
associated with lower Breslow thickness and were 
independently protective of relapse and death. There was also 
evidence of interaction between BsmI and serum 25OHD levels 
on relapse. 
Aims of MelaViD trial and ancillary studies  
In early supplementation trials, the lack of effect on cancer 
incidence has been attributed to insufficient vitamin D 
supplementation, stressing the need to better study vitamin D 
bioavailability.  
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In order to assess whether vitamin D supplementation could 
improve prognosis of Cutaneous Malignant Melanoma (CMM), 
we planned an Italian multi-centre trial in stage II resected 
melanoma patients, evaluating the effect of vitamin D 
supplementation and monitoring changes in 25(OH)D.  
We intend also to study in detail the biology of VDR on vitamin 
D metabolism and in relation to CMM prognosis, looking at the 
association between 25(OH)D and VDR polymorphisms with 
Breslow thickness, the most important prognostic factor of 
CMM. In fact, tumour thickness could be the result of an effect 
on cell proliferation, and this study could give more information 
on functional effects of VDR and on the mechanisms that 
potentially make the vitamin D important in cancer development. 
We will study gene–gene interactions and changes in vitamin D 
metabolites, investigating how metabolism and biology of 
vitamin D interacts with environmental, anthropometrical and 
nutritional factors and contributes to cancer progression.  
Some of the findings from this study will be of large interest also 
for a wide spectrum of cancers. 
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Nutritional support in cancer 
D Alterio 
Division of Radiotherapy, European Institute of Oncology, Milan, Italy 
In a contest of multidisciplinary approach, an adequate 
nutritional support should be considered of fundamental 
importance as supportive therapy in patients treated with 
radiotherapy for malignant tumours. Radiation therapy, in fact, 
produces an acute mucosae inflammation and, after the end of 
treatment, a chronic soft tissues fibrosis, which could produce a 
transient or a definitive alteration of food intake and/or food 
absorption. For these reasons, patients taking radiation therapy 
should be evaluated prior to treatment and offered specialized 
nutritional counselling in order to optimize the treatment and 
prevent radiation-related side effects. In head and neck and 
thoracic regions, acute radiotherapy-related dysphagia is due to 
the inflammatory process of irradiated tissue (oral cavity, 
pharyngeal and oesophagus mucosa) with the development of 
mucositis, oedema and pain. After the end of treatment, late 
dysphagia might be due to soft tissues fibrosis, chronic 
lymphedema and damage to neural tissue. Any hindrance to 
oral food intake should be therefore prevented and adequately 
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supported. During the first phases of pharyngeal mucositis, oral 
supplementation is used when oral intake is still permitted. 
Subsequently, when patients cannot adequately swallow, 
feeding by tube is usually given. Tube feeding  nutrition can be 
performed by a nasogastric tube (generally not preferred and 
used only for short period because of its negative cosmetic 
impact and because of the high risk of mucosal injury, sinusitis 
and aspiration) or by gastrostomy (percutaneous endoscopic 
gastrostomy – PEG). 
Apart from the patient’s quality of life, the clinically relevant 
negative impact of dysphagia and the subsequent weight loss in 
response to anti-cancer therapies is well known [4, 10]. These 
results could be explained by the fact that an inadequate patient 
nutritional status may require temporary or definitive treatment 
interruption. For this reason, in recent years, effort has been 
made to prevent and to ameliorate the nutritional deficiency in 
these patients. Despite of these efforts, a range varying from 
10% to 70% of patients suffered weight loss of more than 10% 
when undergoing concomitant chemoradiation to head and neck 
region [11, 1–3, 8, 9).  Moreover, a recent review, focusing on 
nutritional support in head and neck cancer patients [5], showed 
that dietary counselling performed by a professional dietician 
resulted in less weight loss and improved oral intake compared 
to when dietary counselling was given by a nurse and/or from 
general advice or a nutritional booklet or not at all. These results 
were also confirmed in a recent randomized trial in which 
patients treated with intensive nutrition intervention following the 
American Dietetic Association medical nutrition therapy protocol 
resulted to have a higher intake of calories and proteins 
compared to patients advised generally or with booklets [7].  
Radiation therapy to the abdominal or pelvic region has different 
consequences. These patients may experience radiation-
induced enteritis resulting in intestinal malabsorption. Also, for 
gastrointestinal tumours, a recent study, although performed 
with a limited number of patients, showed that the worsening of 
nutritional status resulted to be associated with worse results of 
anti-cancer therapies [6].  
In conclusion, controlled clinical trials and Institutional 
guidelines are strongly recommended in order to optimize the 
nutritional assessment and intervention for oncologic patients 
undergoing radiation therapy.  
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Anti-oxidants and other bioactive 
compounds in the Mediterranean diet and 
cancer prevention  
C Galli 
Department of Pharmacological Science, University of Milan, Italy 
Correspondence to: claudio.galli@unimi.it
The uncontrolled production of free radicals, activated by 
oxidative stress, is considered a relevant factor in 
carcinogenesis [6]. As a consequence, interest in the possible 
roles of antioxidants (AO) as components of the diet or as 
supplements, as well as of natural bioactive compounds 
endowed of modulatory activity with respect to these events [9] 
has greatly grown in the last years.  In this respect, the 
Mediterranean diet, especially the one that has been defined in 
greater details, i.e. that typical of the Southern European 
countries of Europe, is characterized by a high consumption of 
food items, i.e. vegetables and fruits, that are rich in AO.  This 
has provided the basis of studies of the relationships 
(correlations/associations) between dietary AO and incidence of 
cancer.  It should be noted, however, that the typical 
Mediterranean diet is characterized also by other features (e.g. 
low contents of saturated fatty acids, animal proteins, simple 
sugars and appreciable consumption of fish) that may contribute 
to affect the possible relationships, thus making more complex 
the interpretation of the results.  
Experiments in vitro and in animal models may provide some 
information on the mechanisms that involved in the modulation 
of carcinogenesis by selected compounds, but the relevance of 
these approaches to investigate the situation in humans in 
essence is rather limited.  
A number of studies have been carried out in humans, 
concerning the correlations/associations between estimates of 
AO consumption, or AO administrations or endogenous levels 
of AO, on one side, and cancer incidence or effects of 
treatments, on the other.  Various study designs have been 
applied, from observational studies, e.g. case-control, cohort, to 
controlled randomized clinical trials, on rather different 
population sizes and of different duration, but the results are 
somewhat contradictory.  
It should be considered, however, that relevant unresolved 
issues (both conceptual and practical) make the approach to 
this research area rather complex and difficult:   
(a) Difficulties in the evaluation of the oxidative stress 
status ‘in vivo’, due to the lack of fully validated 
‘biomarkers’ [2] generally applicable to chronic 
diseases, e.g. cardiovascular disease.  
(b)  The extremely high number of compounds endowed of 
AO and biological activities in many foods, up to 
25,000 different compounds [1] and their variability 
(due to genetic and environmental factors) make their 
identification and quantification in complex diets rather 
difficult.  
(c)  In addition, research aimed to investigate the 
modulation of processes, such as carcinogenesis, 
following the intakes of these compounds, face a 
number of problems dependent upon the study design.  
1.  Intake of foods rich in various AO: 
bioavailability, metabolism, interactions 
between the various compounds, from the 
intestinal absorption (interactions with 
transporters and transcription factors) to the 
functional ones (potentiation or inhibition) and 
doses required to reach active concentrations 
in the body.   
2.  Studies with pure compounds based on a 
‘pharmacological’ approach (i.e. high doses of 
a single compound), on one side, may allow 
the evaluation of the role of the compound at 
study, but on the other, these studies are 
based on strategies that are not biologically 
(and nutritionally) correct: pro-oxidant effects 
of high doses, interference with the 
bioavailability and the activities of other AO in 
the body or with endogenous AO systems.  
Key aspects in the design of these studies, in addition to the 
identification and quantification of the AO compounds in foods, 
are the assessment of the AO potential of the subject (e.g. 
plasma anti-oxidant capacity), of the plasma levels of the 
compounds or at least of the main AO (vitamins or non-
vitamins, e.g. flavonoids, phenols, carotenoids, etc.) and of their 
major metabolites.  These data need to be correlated, on one 
side, with the estimated (epidemiological studies) or the 
administered (controlled studies) amounts of AO, and, on the 
other, with pathophysiological data of clinical relevance.  In 
addition, it should be considered that AO, even when poorly 
absorbed, may act at the gastrointestinal site, where they reach 
concentrations considerably higher than in the rest of the body 
and where they may play important roles in protecting the 
gastrointestinal tract itself from oxidative damage and in 
delaying the development of stomach, colon and rectal cancers 
[3].  
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On the basis of these considerations and of the critical 
evaluation of the vast literature that concerns major human 
studies and meta-analyses available, with attention to the 
situation in the Mediterranean area, and considering also the 
strength of the evidence, the following conclusions can be 
drawn: 
(a)  Convincing evidence: Several studies, especially those 
carried out with a case-control protocol [8], provide 
convincing evidence that dietary AO, especially those 
in the Mediterranean diet [5], exert protective effects 
on certain cancers, e.g. prostate, oesophagus, colon, 
bladder, especially in the case of lycopene and 
tocopherols. 
(b) Probable evidence: A certain number of studies 
provide probable evidence of protective effects, 
especially of betacarotene and vitamin C on breast 
cancer risk in post-menopausal women [7].  
(c)  No effect or insufficient evidence:   The majority of the 
studies, meta-analyses and reviews, indicate that there 
is no effect or insufficient evidence of a relationship 
between dietary AO and cancer prevention.  
In general, the main AO involved in the protective effects are 
vitamins E, D and C, and carotenoids, especially lycopene.  On 
the other side, since the total anti-oxidant status declines during 
cancer treatment [4], supplementation of AO in association with 
the pharmacological treatments appears to be justified.  There 
is also a general agreement that more adequate intervention 
and observational studies (number of subjects, duration of the 
studies) are needed to reach conclusions. It should be added 
also that studies with single and pure compounds do not 
generally lead to favourable effects. 
It is generally agreed that the available knowledge indicates that 
the efficacy of natural AO is greater when consumed as 
component foods in the diet.  There is also the consensus that 
recommendations to increase fruit and vegetable consumption 
are justified, since they contribute to the prevention of a number 
of chronic diseases including cancer.  In addition, this dietary 
strategy appears to be associated with complementary healthy 
modifications of the diet (reduction of calories, of the 
consumption of meat and of fat intakes while favouring a 
healthier fat composition) and facilitates lifestyle improvements, 
e.g. weight control also through physical activity.     
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Components of Mediterranean diet in the 
prevention of cancer 
C La Vecchia 
Istituto di Ricerche Farmacologiche 'Mario Negri' Milano e Università 
degli Studi di Milano, Milano, Italy 
‘Mediterranean diet’ has been associated with reduced risk not 
only of cardiovascular disease but also of cancer at various 
sites. Selected aspects of the Mediterranean diet have been 
related to cancer risk; a series of case-control studies 
conducted in Italy since the early 1980s on over 15,000 cases 
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of 20 cancer sites, and a similar number controls. For most 
epithelial cancers, and particularly for digestive tract cancers, 
the risk decreased with increasing vegetable and fruit 
consumption, with relative risks between 0.3 and 0.7 for the 
highest versus the lowest tertile. A number of vitamins and other 
micronutrients or food components (including carotenoids, 
lycopene and flavonoids) showed an inverse relation with 
cancer risk. With reference to flavonoids, our data provided 
support for a protective role of flavanones on upper 
aerodigestive tract, proanthocyanidins on gastric cancer, 
flavonols and proanthocyanidins on colorectal, flavonols and 
flavones on breast, and isoflavones on ovarian cancers. 
However, the components responsible for the favourable effect 
of a diet rich in vegetables and fruit remain largely undefined. 
Fish, and consequently, a diet rich in n-3 fatty acids also tended 
to be favourable diet indicators. In contrast, subjects reporting 
frequent red meat intake showed elevated risks for several 
common neoplasms. Whole grain food (and hence fibre) intake 
was related to reduced risk of several cancers, particularly of 
the upper digestive tract, but refined grain intake and, 
consequently, glycaemic load and glycaemic index were 
associated with increased risk of different types of cancers. 
Olive oil—the major common characteristic of diet in various 
parts of the Mediterranean—is a major source of 
monounsaturated fats in Mediterranean countries but also an 
important source of several micronutrients and food 
components. It appears to be a favourable indicator of the risk 
of various common cancers, particularly of the (upper) digestive 
tract but also of the colorectum, breast and ovary. 
 
Nursing assessment as part of a 
multidisciplinary approach to nutritional 
assessment  
G Magon 
Servizi Assistenziali, European Institute of Oncology, Milan, Italy 
In this report, I will aim to define the characteristics of the 
nursing appraisal that facilitates a nutritional assessment of 
cancer patients.  
I will begin with some important quotes, the first being one from 
Florence Nightingale (this year marking the one hundredth 
anniversary of her death) in 1860 in her publication ‘Notes on 
Nursing’, a founding text for modern nursing care (so much so 
that the introduction reads ‘What it is, and What it is not’), 
devotes an entire chapter to ‘Taking Food’. 
Virginia Henderson in the declination of what constitutes the 
thinking behind the production of theory (of the most notable in 
International circles), identifies 14 nursing care needs that are 
common to every human being, which include eating and 
drinking.  
We can, therefore, say that the concept of nutritional needs is 
historically recognised as part of specific nursing interventions, 
which are to be activated where required or where potentially 
required. Today, pre-registration nursing courses require the 
study of nutrition, and the documentation systems require 
detailed records of the characteristics of that need.  
Time passes quickly and looking at the present day and the 
context here in Lombardy, we cannot fail to note, always more 
stringently, that health care organisations, and their employees 
are required to demonstrate (through compliance with 
standards) the processes to which we subject our patients (or to 
put it as Virginia Henderson—the beneficiaries of our 
intervention). The definition of specific standards for nutrition 
and nutritional therapy (e.g. AOP 1.6, COP 5, PFE 4, etc.) are 
an example. 
I have deliberately quoted the context of Lombardy for the 
implementation of the standards of Joint Commission, but I 
must mention the urban context as the Local Health Agency of 
Milan has adopted the Guidelines in the Prevention of 
Malnutrition.  
With all of these requirements, comes the task of analysing 
patient’s notes regarding aspects that make reference to diet, 
supplemented by research to develop a thesis of a student 
dietician with the same goal.  
In agreement with the Dietetic service of the EIO, we decided to 
deal with this issue by allowing a multidisciplinary team, 
including nurses and dieticians, to move from the concept of 
identification of nutritional needs, towards an assessment of the 
nutritional status of the oncology patient. This requires a 
multidisciplinary approach in which there is clarity regarding 
completeness and accuracy of data to be collected, definition of 
responsibility and definition of timeframes (in this case, there is 
the necessity to consider continuity of care). With regards to 
completeness and accuracy of data collection, we have 
included a focus of interest on the evaluation of nutritional 
status in the process that has led to the development of new 
nursing documentation (today paper, tomorrow computerized 
and integrated with other health care professionals notes). This 
project of revision anticipates the passage towards a 
documentation oriented to the identification of a Nursing 
Minimum Data Set (NMDS) and to the identification of existing
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specific references to nutritional status (e.g. weight loss in the 
last three–six months, glucose intolerance, etc.). The working 
group, drawing on the scientific production by the Oncology 
Nursing Association has led to the development of an NMDS of 
48 outcomes, grouped into 13 categories, one of which is that of 
NUTRITIONAL STATUS. 
In relation to the accuracy of data collection, we have focused 
the discussion on what are the necessary data to investigate 
and in which phases of the nursing assessment. We have 
identified the need to investigate normal weight, weight changes 
in the last three months, calculation of the body mass index, 
capacity/limitations in the assumption of food, reporting of food 
intake in order to cover calorific needs and the definition of 
‘items’ in order to activate a dietetic consultation/referral. For the 
definition of this last aspect, we made a choice that was in line 
with the policy and characteristics of the EIO and have used the 
terminology of the Common Terminology Criteria for Adverse 
Events (CTCAE version n°4) from the National Cancer Institute 
(USA). 
The definition of levels of responsibility is a direct consequence 
of the adoption of valid nursing documentation (Palese et al 
2006) a new procedure has also been developed 
(DIE.PG.0087.D) relating to diet and clinical nutrition, in which 
responsibilities are described (point 4) and the operating 
procedures are outlined (point 5), as well as the criteria for 
activating referral to the dietician (point 5.1). The introduction of 
the Primary Nursing model of care (the project started in 
October 2010) is a cornerstone in the concept of taking care of 
the person in need and in the planning of nursing care, both of 
which relate to individual responsibility not only with treatment 
(of particular interest to the medico legal representative) but, 
above all, in treatment outcomes.  
Finally, we have considered the theme of time frames, or ‘What 
time is appropriate to enable the assessment of nutritional 
requirements’; in EIO, this is already active during pre-operative 
outpatient visit with the participation of the Nursing Case 
Manager in the detection of weight loss (or also weight gain in 
some cases), reporting restrictions on food intake and 
consequent activation of a dietician referral and counselling to 
allow corrective interventions.   
During hospitalization, supervision is provided as outlined 
previously, while during discharge, multidisciplinary 
collaboration is fundamental to initiate an effective health 
education intervention relating to the clinical condition of the 
patient.  
During the outpatient phase, patients continue to undergo 
assessment in the detection of outcomes relating to the dietetic
consultation and multidisciplinary collaboration (important 
collaboration with the enterostomy). We have provided a 
telephone follow-up service for hospitalized patients, but, above 
all, we aim for more, in terms of completeness of the service, 
activation of a 24-h outpatient service—this service was created 
with the goal of allowing direct access to the EIO, in case of 
urgent problems, without having to pass via a general medical 
doctor. This provides access for patients previously treated at 
the Institute, which include also those patients with problems 
relating to nutrition and to the use of safeguards to promote 
food intake.  
Palese A, Cabarcas GR, Dotti R and Riboli O. Documentazione 
scritta (consegne e piani di assistenza). Assistenza 
infermieristica e ricerca 2006; 25: 109-114. 
 
HEN study: home enteral nutrition in 
malnourished patients after major surgery 
for gastrointestinal malignancy 
S Colatruglio
1 and F Valoriani
2  
1  Struttura Semplice di Nutrizione Clinica, National Tumour Institute, 
Milan, Italy 
2 Dietetic and Clinical Nutrition, European Institute of Oncology, Milan, 
Italy 
 
Background and rational 
The prevalence of malnutrition in patients with gastrointestinal 
malignancy has been reported to range from 26% to 57%; 
weight loss is often present since the beginning of the disease 
and, frequently, the nutritional status further deteriorates 
throughout the treatments. Malnutrition is known to be a risk 
factor in the overall treatment of patients with gastrointestinal 
cancer, and it has a negative impact on the final prognosis [1]. 
Weight loss is associated with increased post-operative 
morbidity and mortality [2], duration and costs of hospital stay, a 
reduction in tolerance to chemotherapy and worsens quality of 
life [3]. Body mass index, recent weight loss and change in food 
intake have been demonstrated to correlate with changes in 
cellular function and clinical outcome; these parameters are 
used to calculate the nutritional risk score in order to identify 
patients who are likely to benefit from nutritional intervention [4]. 
After gastrointestinal surgery, patient’s body weight usually 
declines in the two months following hospital discharge [5]. 
Post-operative and post-discharge administration of oral
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nutritional supplements has been investigated in different 
clinical settings, in six randomised trials, with conflicting findings 
[4,6–10]. 
Enteral nutrition (EN), a cost effective tool, is demonstrated to 
reduce post-operative infectious complications in malnourished 
patients undergoing major gastrointestinal surgery [11]. EN can 
be administrated for long periods through a jejunostomy, a fine 
needle catheter that can be safely positioned during surgery 
[12–13]. Regular monitoring of nutritional status and 
continuation of enteral nutrition in patients after hospital 
discharge might prevent further deterioration of nutritional 
status.  
 
Objective and selection criteria 
The aim of this study is to evaluate the efficacy of home enteral 
nutrition (HEN) on the nutritional status, the quality of life and 
tolerance to chemotherapy in malnourished patients who 
undergo major gastrointestinal surgery for malignancy. The 
primary objective is the maintenance of nutritional status after 
hospital discharge, and secondary objectives are the 
improvement in quality of life and tolerance to chemotherapy. 
Inclusion Criteria: both genders over 18 years of age, 
documented cancer of the gastrointestinal tract (oesophagus, 
stomach, pancreas, biliary tract), candidate for major elective 
surgery, pre-operative nutritional risk score > 3 and written 
informed consent. 
Exclusion Criteria: Age < 18 years, Karnofsky index < 60, renal 
failure (ongoing haemodialysis or plasma creatinine > 3 mg/dl), 
respiratory failure (arterial blood PaO2 < 70 mmHg), ASA score 
= 4 or 5, Child-Pugh class C, short bowel syndrome, pregnancy, 
emergency operation and foreign residence or residence in 
Italian region with no regulation designed for home artificial 
nutrition. 
 
Study plan 
General design issues: Phase III, mono-centre, controlled, 
open-label, two-parallel groups, randomized, clinical trial and 
the type of comparison is observation. The study is promoted by 
the National Cancer Institute and the European Institute of 
Oncology, Milan, Italy. 
All patients fulfilling the selection criteria will be included and 
randomized in the study; the planned enrolment is 140 patients 
70 in each group) over a period of two years. All patients will 
continue observation for six months after discharge. In all 
patients included in the study, a fine needle catheter 
jejunostomy will be implanted at the end of the scheduled 
surgery; NE will start on post-operative day 1 and progressively 
increase, with the objective of supplying 25 kcal/kg b.w. and 
0.2–0.25 g nitrogen/kg b.w. daily. Before discharge patients will 
be randomized to receive either home enteral nutrition 
(treatment group) or nutritional counselling (control group). In 
the HEN group, the planned nutrition will cover the basal energy 
requirement calculated with the Harris Benedict formula, it will 
be administrated preferentially through an integration of oral 
diet. Enteral Nutrition will include any standard polymeric 
formula providing 1–1.5 kcal/ml with carbohydrates 50%–60%, 
lipids 25%–35% and protein 12%–20%. HEN can be withdrawn 
in the treated group, after two months from discharge, whenever 
a weight gain ≥ 5% is reported, and oral alimentation is regular 
and adequate. In the control group, specific nutritional 
indications including total energy and protein requirements will 
be provided to patients and high-calorie oral supplements will 
be prescribed whenever necessary.  
The HEN can be started in patients of the control group if a 
further weight loss ≥5% is reported. Anthropometric, 
biochemical and functional measures will be used for 
assessment and monitoring of the nutritional status, before 
discharge, and one, two, four and six months after discharge. 
Quality of life is assessed at hospital admission and two months 
after discharge, using the self-administrated FAACT 
questionnaire; the tolerance to chemotherapy is evaluated by 
the ratio CT planned/CT administered; numbers and degrees of 
side effects were scored in accordance to WHO classification 
for toxicity.  
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Physical activity and cancer: epidemiologic 
evidences 
D Palli, B Bendinelli, G Masala, D Occhini and M Castaldo 
Nutritional and Molecular Epidemiology Unit, Cancer Research and 
Prevention Institute (ISPO), Florence, Italy 
In the last Expert Report ‘Food, Nutrition, Physical Activity and 
the Prevention of Cancer: A Global Perspective’, 2007), jointly 
produced from World Cancer Research Fund (WCRF) and the 
American Institute for Cancer Research (AICR), the results of a 
systematic review of the literature concerning risk factor for 
cancer together with a series of recommendations for cancer 
prevention are reported. The document recommends  ‘physical 
activity as part of everyday life’ in order to reduce cancer risk. In 
particular, there is convincing epidemiologic evidence of a 
protective effect of physical activity on colon cancer risk, 
probable evidence for breast (in post-menopausal women) and 
endometrium cancer risk and suggestive evidence for lung, 
pancreas and breast (pre-menopause) cancer risk. More recent 
literature confirms the opinions of the WCRF/IACR expert panel.  
In addition to the general beneficial effect of weight loss and 
change in body composition mediated by physical exercise, 
other specific and independent mechanisms were hypothesized 
for the association between physical activity and reduced risk 
for several kinds of cancer. The influence of physical activity on 
sexual steroid hormones  (breast, endometrium, prostate and 
colorectal cancer), on metabolic hormones (breast, colon and 
pancreatic cancer), on gut motility (colon and pancreatic cancer) 
and on immuno-modulation (breast and endometrium cancer) 
was discussed. 
In epidemiological studies, three main classifications of physical 
activity are used: 
(a) type of physical activity (occupational, household, 
transport and recreational); 
(b)  intensity of exercise indicated by metabolic equivalent, 
ratio between the energy spent by a subject during an 
activity and the resting metabolic rate in the same time; 
(c)  physical activity level, mean level of physical activity 
during a day (ratio between the daily total energy 
expenditure and the basal energy expenditure). 
In these types of studies, physical activity is rarely measured 
with precision. Physical activity questionnaires (PAQs) are the 
tools most frequently reported in the literature; however, some 
concerns emerged about the use of PAQs:   
(a) there are differences among studies as to what is 
considered ‘physical activity’ (recreational, sports, 
working ...); 
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(b)  in the literature, different kinds of PAQ are used, thus 
the comparison between studies is quite difficult; 
(c) physically active people tend to be more health 
conscious (non smokers, healthy diet) than sedentary 
people, thus the collection of these confounding factors 
is mandatory in studies on the association between 
physical activity and cancer risk; 
(d)  people tend to report vigorous and recreational activity 
more accurately than other kinds of activities (reporting 
bias). 
Instruments for a more objective measurement of physical 
activity include: pedometers, heart rate monitors and 
accelerometers. A good estimation of the total daily physical 
activity may be, however, achieved by the simultaneous use of 
a heart rate monitor and an accelerometer (Actiheart monitor). 
A physical activity and diet intervention trial to reduce 
mammographic breast density in post-menopausal women (a 
strong risk factor for breast cancer) is ongoing in the Nutritional 
and Molecular Epidemiology Unit. It is a factorial randomized 
trial conducted in post-menopausal women at increased risk of 
breast cancer (breast density > 50% in mammographic 
examinations performed in the frame of the local screening 
program). A structured 24-month intervention is performed in 
order to evaluate the effectiveness of reducing mammographic 
density, of an increasing in moderate exercise and/or of a 
modification in the diet according to the WCRF 2007 
recommendations.  
 
Conclusions 
Today, it is scientifically proven that physical inactivity is a key 
risk factor for chronic diseases including cancer, but a growing 
number of people are not achieving the levels of physical 
activity recommended for a good health. In cancer control 
research related to physical activity it seems necessary to focus 
on understanding the type and amount of physical activity that 
brings the greatest benefit in terms of primary prevention. We 
also need to determine how to increase physical activity in 
populations and how to improve the performance of 
‘measurement methods’ to be used in large-scale studies.  
 
Lung cancer and diet: preliminary results of 
the COSMOS study 
P Gnagnarella
1, G Veronesi
2, R Bertolotti
2, M Bellomi
3, L 
Spaggiari
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4 and P Maisonneuve
1 
1Divisione Epidemiology and Biostatistics, 
2Department of Thoracic 
Surgery, 
3Department of Radiology, European Institute of Oncology, 
Milan, Italy.  
4  Nutrition and Molecular Epidemiology Unit, Cancer Research and 
Prevention Institute (ISPO), Florence, Italy. 
 
Introduction  
Cancer of the lung is the most common type of cancer in the 
world [3]. The major risk factors are tobacco smoking followed 
by occupational exposures. Epidemiological research has 
provided evidence that dietary habits may play an important role 
in lung cancer aetiology [12]. The 2007 WCRF/AICR expert 
report concludes that increased fruit intake and food containing 
carotenoids probably protect against lung cancer, but there are 
only limited evidence suggesting that vegetables and foods 
containing selenium and quercetin protect against lung cancer. 
The association still remains unclear [2, 10] in smokers. There 
is also limited evidence suggesting that red meat, processed 
meat, total fat and butter are causes of lung cancer [12]. 
As part of the COSMOS study (Continuous Observation of 
Smoking Subjects) designed to implement a comprehensive 
screening programme for early diagnosis of lung cancer in high-
risk volunteers in North West Italy [11], we assessed dietary 
intake of participants using a semi-quantitative food frequency 
questionnaire. In this study, we report the preliminary results 
examining the association between nutrients intake and lung 
cancer risk in high-risk volunteers. 
 
Materials and methods 
The COSMOS study is a single-centre non-randomized lung 
cancer screening trial, conducted in Northern Italy. Details of 
participants, screening protocol and diagnostic work up have 
been published elsewhere [11]. Briefly, we enrolled 
asymptomatic volunteers, age 50 years or more, who were 
current or former heavy (≥20 pack-years) smokers in 2004. Ex-
smokers had stopped not more than ten years previously. 
Those with malignant disease (except treated non-melanoma 
skin cancer) or a diagnosis of malignant disease within the 
previous five years were excluded. All recruited volunteers gave 
written consent to receive annual low-dose spiral computed 
tomography (LD-CT) for five consecutive years. They also 
compiled a self-reporting questionnaire investigating respiratory 
symptoms, smoking habits, exposure to other risk factors, 
medical and family history. The study was approved by the 
ethics committee of the European Institute of Oncology. 
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Table 1: Demographic characteristic, BMI and smoking habits in COSMOS participants 
Dietary assessment 
At baseline, usual diet before the enrolment was measured by a 
semi-quantitative food frequency questionnaire originally 
developed for the EPIC-Italy study [5, 6]. It is a validated self-
administered instrument [7], estimating the daily intake of foods 
and nutrients, referred to the previous year. It contains 14 
sections with 248 questions concerning 188 different food items, 
and 17 sets of pictures showing a small, medium and large 
portion size are also available. The absolute frequency of 
consumption of each item is assessed, reporting the number of 
times a given food item is consumed (per day, week, month or 
year). The consumption of vitamins and minerals supplements 
has also been collected to complete the nutrient intake of 
volunteers. Participants reported the brand name, the frequency 
of consumptions per day or per week and the numbers of 
months, referred to the previous year. 
 
Statistical analysis 
The average daily quantities of foods, energy and nutrients 
consumed by participants have been calculated using a 
computer program (Pale et al, 2003), non-including supplement 
intake.  Nutrient intake has been calculated according to a 
specifically developed Italian food composition database for 
epidemiological study [8].  
Cox proportional Hazards regression was used to analyse the 
association between nutrients intake and risk of lung cancer. 
We divided the consumption of nutrients (macro- and 
micronutrients) according to quartiles of consumptions. 
Multivariate models were adjusted for age, sex, smoking status, 
number of pack-years, past history of emphysema or chronic 
obstructive pulmonary disease (COPD) and total energy intake. 
 
Results and conclusion 
During 19,616 person-years of observation, 134 participants of 
the COSMOS study were diagnosed with lung cancer. Initially, 
5203 subjects were enrolled, but dietary information was 
obtained for 4363 participants (84%). After exclusion of patients 
with abnormal dietary values (outliers), the final study 
population included 4337 subjects (Table 1). Median age at 
baseline was 57 years (50–84), 20% of subjects were ex-
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Table 2: Median energy and nutrients intake from food in all study population (4337) compared to the national recommendations [4] 
smokers and 80% were current smokers. The percentage of 
supplement users was (15%, 648 subjects) higher compared 
with the Italian food consumption survey (5%) or with other 
European studies (3%–8%) [1]. 
Mean energy intake reported by the study population was 2254 
kcal (9428 kJ) per day (Table 2). Protein contributed on average 
for 16% of food energy, fat for 34%, carbohydrates for 43% and 
alcohol for 8%. We observed a higher intake of total fat, total
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Table 3: Hazard ratios (HRs) (95% CI)
ç for lung cancer, according to quartiles of consumption of specific nutrients for all participants (4337) 
saturated fatty acids (FSA) (12%), cholesterol (353 mg), soluble 
carbohydrate (17%) and a low intake of dietary fibre (19 g), 
compared to the national recommendations [4]. These data are 
in line with the results of the last Italian National Food 
Consumption Survey (INRAN-SACI 2005) [9]. On average, the 
intake for mineral and vitamins were adequate to cover the 
recommendations, except for women who did not reach 
recommended levels of calcium and vitamin D. The data 
indicate that our high-risk population had a diet poorer in anti-
oxidant vitamins (mainly in β-Carotene and vitamin E) compared 
to the National Survey [9]. 
In our study, no significant association was found between 
either macro- or micronutrients and lung cancer risk, when we 
compared the highest versus lowest quartiles of consumption 
(Table 3). The evidence of the association between nutrients 
and lung cancer risk are actually scarce in literature. No 
conclusion can be drawn for macronutrients, dietary fibre; 
alcohol, vitamins (vitamin A; thiamine; riboflavin; niacin; vitamin 
B6; folate; vitamin C; vitamin E), minerals (calcium; copper; iron; 
zinc) and other bioactive compounds (pro-vitamin A 
carotenoids, lycopene, flavonoids) as reported by the 2007 
WCRF/AICR expert report. Only carotenoids (from foods) 
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probably protect against lung cancer. Limited is the evidence for 
foods containing selenium and total fat, but our results do not 
support these from previous studies and do not help to 
understand the association with other components included in 
our analysis. 
The null association reported may be explained in part by the 
strong association between lung cancer and smoking, 
influencing the effect of the single nutrients. In addition, 
smokers tend to have a less healthy diet and to be leaner than 
non-smokers, but our population results to be health conscious. 
We found a high percentage of supplement users, and 
overweight and obese (together 56%). These factors may have 
influenced our results. Further analysis needs to investigate the 
associations between dietary nutrients and the risk of lung 
cancer risk in subgroups (sex, smoking status, histological 
subtype o) in our population. To complete the analysis, we will 
also include nutrients intake (vitamins and minerals) coming 
from supplements.  
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Nutrition and Tumours 
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Background  
Breast cancer (BC) is the most common malignancy in women 
and is their leading cause of death from cancer. In high-income 
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countries, the incidence of BC has increased steadily over the 
past decades, but BC mortality is declining, suggesting a benefit 
from early detection and more effective treatment. BC survivors 
are constantly increasing, and research investment for the 
identification of modifiable factors associated with BC 
recurrences is increasing too. Western lifestyle, characterized 
by low levels of physical activity and a diet rich in refined 
carbohydrates, animal fats and protein is associated with high 
prevalence of metabolic syndrome, insulin resistance and high 
serum levels of sex hormones and growth factors. All these 
factors are strongly related with BC risk and BC prognosis but 
are potentially modified through diet and lifestyle. 
 
Method  
The present work summarizes the metabolic, hormonal and 
dietary correlates of increased risk of BC and BC recurrences. 
 
Results  
Obesity  is associated with an increased risk of  BC after 
menopause, while no association or slightly reduced BC risk 
has been found before menopause. Preventing weight gain in 
adulthood, however, would decrease the overall burden of BC. 
Obesity has been shown to adversely affect prognosis in both 
pre- and post-menopausal BC, after controlling for clinical and 
pathological prognostic factors. High serum levels of steroid sex 
hormones and of bio-available insulin-like growth factor I (IGF-I) 
are associated with an increased risk of BC. Furthermore, 
insulin and markers of insulin resistance, such as abdominal 
obesity, high blood glucose, high serum level of testosterone, 
and metabolic syndrome, may affect both BC incidence and 
prognosis. Sedentary lifestyle is associated with increased BC 
risk, both before and after menopause. Women who practice 
regularly at least some physical activity decrease their BC risk 
by 30% or more, and there is increasing evidence that physical 
activity may protect also against BC recurrences. The 
association between dietary fat intake and BC is an highly 
controversial topic in epidemiology. Results of the Women 
Initiative on Nutrition Study (WINS), a randomized dietary 
prevention trial, suggested a strong benefit of dietary fat 
reduction on relapse-free survival with the strongest protection 
for hormone receptor-negative BC. The Women's Healthy 
Eating and Living (WHEL) Study tested whether a dietary 
pattern high in vegetables, fruit and fiber and low in fat might 
reduce BC relapses in women with early-stage BC. The primary 
analyses of the WHEL study did not demonstrate an event-free 
survival advantage in patients randomized in the dietary arm. 
This trial, however, was isocaloric and the intervention group did 
not loose weight. 
 
Conclusion  
The briefly reviewed factors are strongly related to diet and 
lifestyle and may be potentially modified. Our DIANA (Diet and 
Androgens) intervention trials demonstrated that a sustainable 
dietary modification aimed at lowering insulin levels, based on 
Mediterranean and macrobiotic dietary principles, can reduce 
body weight, metabolic syndrome and the bioavailability of sex-
hormones and growth factors. Together with other studies 
showing that Mediterranean diet can revert metabolic 
syndrome, these results suggest that dietary changes should be 
recommended for both BC prevention and treatment.  
 
Dietary patterns and cancer in Italy and 
Europe 
V Krogh and C Agnoli 
National Tumour Institute, Milan, Italy 
Traditional analyses in nutritional epidemiology typically 
examine the relationship between diet and diseases focusing on 
single nutrients or foods. However, due to limitations in this 
approach, some decades ago a new and more holistic way to 
look at the association between diet and health spread: the 
dietary pattern approach. The main reasons for this shift are:  
- persons do not eat isolated nutrients or single foods, 
but a wide variety of foods with combinations of 
nutrients that may be synergistic;  
 - high correlation between nutrients make it difficult to 
study their separate effects; 
 - the effect of a single nutrient may be to small to be 
detect; 
  - analyses based on a large number of nutrients or 
food items may produce statistically significant 
associations simply by chance, 
 - since nutrients intake is associated with some dietary 
patterns, results based on this analysis could be 
confused by the effect of the dietary pattern. 
Dietary patterns, which take into account cumulative and 
interactive effects among dietary components and reflect real-
world dietary preferences, may be particularly suitable when
 20  www.ecancermedicalscience.com 
C
o
n
f
e
r
e
n
c
e
 
R
e
p
o
r
tecancer 2010, 4:205 
 
 
 
Figure 1. Methods for defining dietary patterns (modified from Schulze & Hoffmann, Br J Nutr 2006).
several dietary components are involved in the onset of a 
disease. 
In dietary pattern analysis, the collinearity of nutrients and foods 
could be exploited with advantage because dietary patterns are 
characterized on the basis of eating behaviour; furthermore, the 
study of dietary patterns could have important implications 
because they are easy to translate into dietary guidelines. 
 
Methods for defining dietary patterns 
 [17] 
There are two main approaches to define dietary patterns (see 
Figure 1): 
(a) ‘a priori’ dietary patterns or diet quality scores: they 
consist of nutritional variables (foods and/or nutrients), 
thought to be important for the health or in a specific 
cultural context, that are quantified and summed to 
provide a comprehensive measure of dietary quality;  
(b) ‘a posteriori’ dietary patterns: they are obtained trough 
statistical modelling of the data at hand. 
 
A priori-defined dietary patterns 
This kind of dietary patterns reflect the current knowledge on 
the relationship between diet and a specific disease and can be 
easy translated into country-specific or culture-specific 
nutritional recommendations. They can be based on dietary 
guidelines, on available scientific evidence on the relationship 
between diet and a specific disease, or on a specific dietary 
tradition. 
Several key issues should be keep in mind when constructing a 
diet quality score: 
- choice of the components to include in the score; 
- choice of the nutritional variables to include in each 
component; 
- choice of the cut-off values; 
- exact quantification of the pattern components; 
- whether adjusting or not for energy intake; 
- decision on the relative contribution of the individual 
components to the total score. 
Several diet quality scores have been developed worldwide; 
below there is a brief explanation of the main scores developed 
in Italy and in Europe and the findings on the relationship 
between adherence to them and cancer risk. 
 
Mediterranean diet score [21] 
Scoring is based on intake of 9 items (see Table 1): vegetables, 
legumes, fruit and nuts, dairy products, cereals, meat and meat 
products, fish, alcohol and the ratio of monounsaturated to 
saturated fat. For most items, consumption above study median 
receives 1 point; all other intakes receive 0 points. For dairy 
products, meat and meat products, consumption below the 
median receives 1 point. Medians are gender specific. For 
ethanol, men who consumed 10–50 g/day and women who 
consumed 5–25 g/day received 1 point; otherwise, the score 
was 0. The range of possible scores is 0 to 9.  
Previous versions of this score included potatoes in the 
vegetables component and did not include fish [20].   
 21  www.ecancermedicalscience.com 
C
o
n
f
e
r
e
n
c
e
 
R
e
p
o
r
tecancer 2010, 4:205 
 
 
Table 1. Components of the Mediterranean diet score and scoring system. 
Mediterranean adequacy index [8]: 
This index is calculated as the ratio between consumption of 
typical Mediterranean food items and consumption of less 
typical Mediterranean food items. 
Mediterranean foods include: bread, cereals, legumes, 
potatoes, vegetables, fruit, nuts, fish, wine and vegetable oils. 
Non-Mediterranean foods include: milk, cheese, meat, eggs, 
animal’s fats and margarines, sweetened beverages, sweets 
and sugar.  
Food items can be expressed as percentage of energy intake, 
g/day, g/1000 kcal, or g/4.2 MJ. 
 
Healthy diet indicator [9] (see Table 1): 
Developed on the basis of the WHO dietary recommendations 
for the prevention of several chronic diseases, it included nine 
components (see Table 2):  saturated fats, polyunsaturated fats, 
protein, complex carbohydrates, fiber, fruit and vegetables, 
pulses/nuts/seeds, monosaccharides and disaccharides, 
cholesterol. For each component, the score is 1 if the intake 
meets to the recommendations, otherwise it is 0. The range of 
possible score is 0 to 9. 
Food-based quality index [10]:  
This index is based on the WHO dietary guidelines and includes 
as components seven food items: fruit and nuts, vegetables, 
cereals, meat, milk, potatoes and cheese. For each component, 
the score is 1 if the intake meets to the recommendations, 
otherwise it is 0. The range of possible score is 0 to 7. 
 
Healthy food index [14]: 
It is calculated by assigning one point to each of the following 
characteristics:  
(a)  not consuming butter, lard or margarine daily; 
(b)  consuming raw or boiled vegetables at least once a 
day; 
(c)  consuming whole bread at least once a day; 
(d)  consuming fruit at least once a day. 
Possible scores, therefore, range from 0 to 4. 
Food pyramid index [12]:  
This index is calculated as the ratio between more fatty food 
items of the Group 1 of the Italian Food Pyramid (i.e. oils, fats, 
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Table 2. Components of the Healthy Diet Indicator and scoring system. Values are percentage of energy intake unless indicated (modified from 
Huijbregts, BMJ 1997) 
sweets, dairy products, red meat, poultry and fish) to those with 
negligible fat content of Group 2 (i.e. pasta, rice, bread and 
legumes). Vegetables and fruit were not included.  
 
Relation between a priori dietary patterns 
and cancer risk 
The Mediterranean diet has gained considerable attention 
recently, and adherence to this diet has been studied 
extensively. Therefore, the vast majority of study investigating 
the relationship between an a priori dietary pattern and cancer 
risk in Europe applied the Mediterranean diet score. Adherence 
to this index was found to be inversely associated to: 
- post-menopausal breast cancer incidence [22]; 
- gastric adenocarcinoma incidence [4]; 
- upper aero-digestive tract cancer incidence [3]; 
- all cancer incidence [1]; 
- all cancer mortality [21]. 
 
Strengths and limitations of a priori dietary 
patterns 
Strengths of a priori dietary patterns include the following 
characteristics: 
- analytically simple to compute; 
- easily reproducible and comparable; 
- usually associated with health outcomes; 
- they may be formulated to investigate the effects of 
diet on specific diseases. 
On the other hand, they have some limitations: 
- those that dichotomize components (e.g. above vs 
below the median intake) do not take into account the 
full range of amounts of foods consumed (problem of 
the extremes of the distribution);  
- subjectivity is introduced in the choice and 
quantification of components; 
- they may not adequately deal with the correlations in 
intake of various dietary factors and nutrient–nutrient 
interactions; 
- limited by available scientific knowledge. 
 
A posteriori-defined dietary patterns 
In data-driven approaches, a large set of dietary variables are 
aggregated and reduced to a smaller set of variables. These 
methods do not require a priori theory on which components 
should be included in the dietary pattern and on their 
quantification. Two main approaches can be applied to derive a 
posteriori dietary patterns: 
(a) factor analysis, based on intercorrelations between 
dietary variables; 
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(b) cluster analysis, based on individual differences in 
mean intakes of dietary constituents. 
Factor analysis: 
Factor analysis is a multi-variate statistical technique, which 
identifies food items that are usually consumed together: it 
aggregates specific dietary variables in factors on the basis of 
the degree to which the variables are correlated to one another 
in the dataset. The resulting factors represent distinct dietary 
patterns, they are uncorrelated with each other and are linear 
combinations of the observed dietary variables that explain the 
variance in the data. 
Factors are not mutually exclusive: on the basis of their diet, 
individuals receive factor scores for each derived factor or 
pattern. Factors are continuous variables that are often 
categorized into quantiles.  
 
Cluster analysis:  
Cluster analysis is a multi-variate statistical technique that 
aggregates individuals into relatively homogeneous subgroups 
(clusters) with similar diets. 
Dietary patterns are derived on the basis of differences in mean 
intakes between subjects, individuals belong to one cluster only. 
Clusters are categorical (nominal) variables. 
 
Reduced rank regression 
Analytical technique that aims at identifying linear functions of 
predictors (e.g. foods) that explain as much variation as 
possible in a set of intermediate response variables (e.g. 
nutrients or biomarkers related to the outcome of interest). The 
resulting factors can then be examined in relation to diseases. 
It is a mix between a priori-defined and a posteriori-defined 
dietary patterns because it uses both dietary data at hand and 
prior knowledge for choosing appropriate response variables. 
 
Reproducibility and validity of a posteriori 
dietary patterns  
Although a posteriori dietary patterns could not be exactly the 
same across studies since they depend on available data, major 
patterns show reasonable reproducibility. Furthermore, 
validation studies found reasonable correlations between data-
driven patterns and nutrients or biomarkers. 
Several  a posteriori-defined dietary patterns have been 
identified in European and Italian studies. 
 
Italian studies  
ORDET cohort (factor analysis) [18,19]: 
- salad vegetables: raw vegetables and olive oil; 
- western: potatoes, red meat, eggs and butter; 
- canteen: pasta and tomato sauce; 
- prudent: cooked vegetables, legumes, fish and low-
alcohol consumption. 
EPIC-Italy Elderly cohort (factor analysis) [13]: 
- prudent: cooked vegetables, legumes and seeds oil; 
- pasta and meat: pasta and other grains, tomato 
sauce, red and processed meats, animal fats, bread 
and wine; 
- olive oil and salad: olive oil, raw vegetables, soups 
and poultry; 
- sweet and dairy: added sugars, sweets, coffee, eggs, 
butter and milk. 
Multicentric case-control study (factor analysis based on 
nutrients) [6,2,7]: 
- animal products: animal protein, animal fats, calcium, 
cholesterol, saturated fats, riboflavin, zinc and 
phosphorus; 
- vitamins and fiber: vitamin C, fiber, folate, potassium, 
β-carotene equivalents, soluble carbohydrates and 
vitamin B6; 
- unsaturated fats: vegetable fats, vitamin E, 
monounsaturated and polyunsaturated fats; 
- starch-rich: starch, vegetable protein and sodium. 
 
European studies  
DIETSCAN pooling cohorts study (factor analysis) [5,11]: It is 
remarkable that this pooling of four cohort studies found the
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Table 3. Association between a posteriori dietary patterns and cancer risk 
same two a posteriori dietary patterns across the European 
studies included:  
- vegetables: vegetables, legumes, citrus fruits, 
berries, pasta, rice, poultry, fish and oils; 
- pork, processed meat and potatoes: pork meat, 
processed meat, potatoes and coffee. 
EPIC-Potsdam cohort (reduced rank regression) [16]: 
- high fat consumption pattern (breast cancer): low 
consumption of bread and fruit juices, high 
consumption of processed meat, fish, butter and other 
animal fats and margarine. 
 
Relation between a posteriori dietary 
patterns and cancer risk 
Table 3 below shows the main findings on the relationship 
between a posteriori dietary patterns and cancer risk: 
In summary, ‘salad vegetables’ pattern was associated with 
reduced breast cancer risk, especially HER2 negative breast 
cancer [18,19]. ‘Animal products’ was associated with increased 
risk of breast [6] and gastric cancer [2]. ‘Unsaturated fats’ 
increased breast cancer risk [6] but reduced colon cancer risk 
[7], while ‘starch-rich’ increased the risk of breast, ovarian [6], 
gastric [2], colon and rectum cancer [7]. ‘Vitamins and fiber’, 
instead, was found to be protective for ovarian [6], gastric [2] 
and rectum cancer [7]. Another pattern based on nutrient, 
labelled ‘vitamin-rich’ and very close in composition to ‘vitamins 
and fibre’, was found to be protective for gastric cancer, while 
the same study found that a ‘traditional’ pattern, characterized 
by high intake of total protein, starch, alcohol, nitrite and N-
nitrosodimethylamine, increased the risk of gastric cancer [15]. 
Finally, ‘high-fat consumption pattern’ was associated with 
increased breast cancer risk.   
 
Strengths and limitations of a posteriori 
dietary patterns 
Strenghts of a priori dietary patterns include the following 
characteristics: 
- they allow for biologic interactions among nutrients; 
- they describe how people really eat; 
- less influenced by a priori knowledge on the 
relationship between diet and diseases. 
On the other hand, they have the following limitations: 
- they do not necessarily represent ’healthy’ versus 
‘unhealthy’ patterns; 
- they may not be appropriate to predict a specific 
disease; 
- limited data on the reproducibility and the validity of 
the methods; 
- subjectivity is introduced in the grouping of dietary 
items, treatment of dietary variables, how to deal the 
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gender differences, how to deal with energy 
adjustment, selecting a final pattern solution. 
 
Major challenges in dietary patterns analysis 
A major challenge in studying the relationship between dietary 
patterns and risk of a specific disease is the selection of the 
best method to quantify dietary patterns. Furthermore, because 
they are composed with a variety of foods and/or nutrients, they 
are not informative about biological mechanisms underlying the 
association between dietary habits and disease. 
Dietary patterns are likely to vary according to gender, culture, 
ethnic group and socio-economic status; therefore, results 
should be replicated in diverse populations. In addition, because 
of changes in food preferences and availability, patterns could 
also change over time. 
 
Conclusion  
To conclude, dietary patterns analysis is a recent method 
proposed to study the relation between a complex exposure, i.e. 
diet and disease risk. This approach has many advantages, but 
because of its limitations, it will not replace analysis based on 
foods and nutrients; instead, it could be useful to complement 
more traditional analysis. In addition, a dietary pattern could 
also be assessed as a covariate when examining the effect of a 
specific nutrient on disease risk.  
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